HMOs in Hydrolyzed Rice Formula Boost Growth

Can a New, Allergy-Friendly Formula Support Growth and Immune Health?

Hydrolyzed rice formulas are a safe, effective choice for non-breastfed infants with cow’s milk allergy. However, research has not yet confirmed if adding specific prebiotic compounds from breast milk, called human milk oligosaccharides (HMOs), to these formulas supports healthy growth. A major new European trial, the RIGHT-GO study, is investigating this precise question by comparing the growth of infants fed a novel HMO-containing rice formula against those given a standard HMO-containing cow’s milk formula.

A Trial Designed to Answer a Key Question on Growth

Led by Hania Szajewska of the Medical University of Warsaw and a consortium of European pediatric allergy experts, the RIGHT-GO study is a randomized, controlled, multi-center trial. It plans to enroll 104 full-term infants, eight months of age or younger, with diagnosed or suspected cow’s milk allergy. These infants will be randomly assigned to one of two groups for four months: one receives the new hydrolyzed rice formula containing HMOs (HRF-HMO), and the other receives a standard, extensively hydrolyzed cow’s milk formula that also contains HMOs (eHF-HMO).

The primary goal is straightforward but vital: to demonstrate that growth, measured by weight-for-age, in infants fed the rice formula is not inferior to growth in those fed the cow’s milk formula. The study uses a precise statistical margin, meaning the rice formula group’s growth must not fall below the control group’s by more than 0.5 standard deviations. Secondary outcomes include other growth measurements, safety, tolerance, and the infant’s health-related quality of life.

Why HMOs Are More Than Just “Extra Ingredients”

The common thread in both formulas is the inclusion of two specific HMOs: 2-fucosyllactose (2’FL) and lacto-N-neotetraose (LNnT) in a 2:1 ratio. These are not live bacteria like probiotics but are specialized prebiotic fibers. In breast milk, HMOs are the third-largest solid component, yet infants cannot digest them. Their primary function is to serve as a selective food source for beneficial gut bacteria, such as Bifidobacterium.

This mechanism is foundational. By promoting a healthy gut microbiome, HMOs help strengthen the intestinal barrier. A robust gut lining acts as a critical defense, preventing harmful pathogens and allergens from passing into the bloodstream. Furthermore, a significant portion of the body’s immune cells reside in gut-associated lymphoid tissue. A microbiome nurtured by HMOs helps “educate” these immune cells, promoting appropriate responses and reducing excessive inflammation linked to allergies. For more on the foundational role of the early gut microbiome, see our guide on Baby Gut Microbiome Boosts Early Immunity Development.

Contextualizing the Research for Parents

This trial is significant because it directly addresses two parental concerns in managing cow’s milk allergy: ensuring safe, symptom-free nutrition and supporting overall health and development. Hydrolyzed rice formulas are already endorsed by expert societies as a safe, plant-based option. This study asks if adding HMOs—components with a clear biological role in immune development—can make them an even more complete option without compromising core growth.

It is important to note that the study’s findings are not yet available, as it is an ongoing protocol. The results will provide specific evidence for this particular formula combination. Parents should understand that not all “prebiotics” or “probiotics” are identical; the specific strains and compounds matter. The research also focuses on a medical indication—cow’s milk allergy—and is not a general recommendation for all infants.

Navigating Practical Choices in Infant Nutrition

For parents navigating a cow’s milk allergy diagnosis, this emerging science highlights key points to discuss with a pediatrician. First, the choice of a hypoallergenic formula should be based on proven efficacy for managing allergy symptoms and supporting growth, which both standard extensively hydrolyzed formulas and hydrolyzed rice formulas offer. Second, the potential added benefit of HMOs for gut and immune health is a growing area of pediatric nutrition science.

This trial may offer future evidence for a rice-based formula that incorporates this immune-supportive dimension. Parents should be aware of other nutritional considerations in infancy, such as the importance of Vitamin D in the First 1,000 Days and the risks of Iron Deficiency from Excess Milk. Always consult a healthcare provider to choose the most appropriate formula for an individual child’s medical needs.

Conclusion

The RIGHT-GO study represents a targeted investigation into improving nutritional options for infants with cow’s milk allergy. By rigorously testing whether a hydrolyzed rice formula with added HMOs supports healthy growth, it aims to provide parents and clinicians with evidence-based choices that address both allergy management and foundational gut health.

Sources:
https://pubmed.ncbi.nlm.nih.gov/42111853/
https://pubmed.ncbi.nlm.nih.gov/42099620/
https://pubmed.ncbi.nlm.nih.gov/42090907/